logo

Abbvie (ABBV)



Trade ABBV now with
  Date
  Headline
5/17/2019 8:51:26 AM AbbVie Provides Update On Depatuxizumab Mafodotin, An Investigational Medicine For Newly Diagnosed Glioblastoma
5/14/2019 8:41:45 AM AbbVie Resolves U.S. HUMIRA Litigation With Boehringer Ingelheim
4/25/2019 7:43:53 AM AbbVie Q1 Net Income $2.456 Bln Or $1.65/shr Vs. $2.783 Bln Or $1.74/shr Last Year
4/18/2019 10:06:35 AM Health Canada Oks SKYRIZI For Treatment Of Moderate To Severe Plaque Psoriasis
4/4/2019 10:02:44 AM AbbVie Announces New Formulary Listings For Hepatitis C Treatment MAVIRET
4/3/2019 11:16:01 PM 10 Best Selling Drugs
3/26/2019 1:03:33 AM AbbVie Announces First Regulatory Approval Of SKYRIZI In Japan
3/22/2019 10:31:14 AM British Columbia PharmaCare Lists AbbVie's Hepatitis C Treatment MAVIRET On Formulary
3/19/2019 8:48:57 AM AbbVie : FDA Places Partial Clinical Hold On Trials On Venetoclax For Investigational Treatment Of Multiple Myeloma
3/7/2019 8:50:09 AM AbbVie Announces Multiple Milestones For Phase 3 CLL14 Venetoclax Study
3/1/2019 7:25:07 AM AbbVie Receives CHMP Positive Opinion For Risankizumab For Moderate To Severe Plaque Psoriasis
2/22/2019 8:06:01 AM AbbVie And Voyager Collaborate To Develop Vectorized Antibodies To Treat Parkinson's Disease And Other Synucleinopathies
2/21/2019 1:26:18 PM AbbVie Declares Quarterly Dividend Of $1.07, Payable May 15/ Record April 15
2/21/2019 1:25:37 PM AbbVie (ABBV) Declares Quarterly Dividend of $ 1.07, Record Date 4/15/2019